RELATED CONTENT
At ASTRO 2015, Mevion highlighted the exceptional results its customers are seeing with the Mevion S250 Series proton therapy system.
January 22, 2016 
Lung cancer is the No. 1 cancer killer in the United States, causing more deaths each year than breast, colon, pancreas and prostate cancers combined. The National Lung Screening Trial proved that computed tomography (CT) lung cancer screening (LCS) can reduce deaths due to lung cancer by at least 20 percent in individuals at high risk. The resulting endorsement of LCS by the United States Preventive Services Task Force means that millions of high-risk Americans will be granted insurance coverage for annual LCS beginning in 2015.
November 11, 2014 
Matakina International announced that the Volpara objective breast density measurement software will be used in the European Union (EU) collaborative Adapting Breast Cancer Screening Strategy Using Personalised Risk Estimation (ASSURE) research project.
January 30, 2013 
June 11, 2010 - Web-based advanced visualization tools are no longer limited by remote access and today provide solutions as robust as their workstation-based counterparts.
June 11, 2010